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Protective role of vitamin B6 (PLP) 
against DNA damage in Drosophila 
models of type 2 diabetes
Chiara Merigliano1, Elisa Mascolo1, Mattia La Torre1, Isabella Saggio1,2 & Fiammetta Vernì  1
Growing evidence shows that improper intake of vitamin B6 increases cancer risk and several studies 
indicate that diabetic patients have a higher risk of developing tumors. We previously demonstrated 
that in Drosophila the deficiency of Pyridoxal 5′ phosphate (PLP), the active form of vitamin B6, 
causes chromosome aberrations (CABs), one of cancer prerequisites, and increases hemolymph 
glucose content. Starting from these data we asked if it was possible to provide a link between the 
aforementioned studies. Thus, we tested the effect of low PLP levels on DNA integrity in diabetic 
cells. To this aim we generated two Drosophila models of type 2 diabetes, the first by impairing 
insulin signaling and the second by rearing flies in high sugar diet. We showed that glucose treatment 
induced CABs in diabetic individuals but not in controls. More interestingly, PLP deficiency caused high 
frequencies of CABs in both diabetic models demonstrating that hyperglycemia, combined to reduced 
PLP level, impairs DNA integrity. PLP-depleted diabetic cells accumulated Advanced Glycation End 
products (AGEs) that largely contribute to CABs as α-lipoic acid, an AGE inhibitor, rescued not only 
AGEs but also CABs. These data, extrapolated to humans, indicate that low PLP levels, impacting on 
DNA integrity, may be considered one of the possible links between diabetes and cancer.
Growing evidence associates micronutrients as minerals and vitamins to genome integrity maintenance showing 
that their deficiency can damage DNA analogously to common carcinogens. Micronutrients act as co-factors or 
substrates for enzymes that counteract genotoxins as well as enzymes working in DNA metabolism (reviewed 
in1). Vitamins belonging to B group as folates (vitamin B9 and its derivatives) and B12 vitamin act as cofactors of 
enzymes involved in the conversion of dUMP in dTMP by the transfer of a methyl group. It has been shown that 
in human cells and rodents2 the impairment of this reaction due to folate and B12 deficiency causes Uracil misin-
corporation, a mutagenic lesion leading to point mutation, micronuclei formation and chromosome aberrations 
(CABs) that are known to contribute to the genesis and progression of human cancers3–5. Another consequence of 
impaired dUMP conversion is nucleotide pool imbalance that can compromise crucial cellular processes as DNA 
synthesis and repair. Impairment of DNA repair has been observed in cultured cells and animal models deprived 
of folates (reviewed in6). Thus, it is not surprising that low folate levels have been correlated with some cancers as 
demonstrated by many epidemiological studies7–10.
Pyridoxal-5′-phosphate (PLP), the active form of vitamin B6, plays a role in protecting cells from DNA 
damage. Mammals produce PLP from vitamers (pyridoxine, pyridoxamine and pyridoxal), which are intro-
duced by the diet and recycled in a “salvage pathway” through the action of two enzymes, Pyridoxal kinase and 
Pyrodoxine/pyridoxamine oxidase. PLP serves as a co-enzyme in approximately 160 enzyme reactions that reg-
ulate metabolism of glucose, lipids, amino acids, heme, DNA/RNA and many neurotransmitters11–13. In addition 
to work as cofactor, vitamin B6 plays antioxidant roles by counteracting the formation of genotoxic compound, 
the Advanced Glycation End-products (AGEs)14,15 and by quenching oxygen reactive species16,17. Given its role in 
numerous metabolic reactions PLP has been associated to many human disorders including diabetes and cancer 
but underlying mechanisms are not fully elucidated (reviewed in14,18–20). High expression level of Pyridoxal kinase 
(PDXK) has been positively correlated with survival of nonsmall cell lung cancer (NSCLC) patients21. In addition, 
Vitamin B6 intake and blood PLP levels were inversely correlated with the colorectal cancer risk22.
We recently demonstrated in Drosophila that PLP deficiency caused either by mutations in the pyridoxal 
kinase-coding gene (dPdxk) or by vitamin B6 antagonists results in chromosome aberrations (CABs) suggesting 
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a role for Pyrodoxal kinase in chromosome integrity maintenance. This function is evolutionarily conserved in 
human and yeast as PDXK depletion by RNA interference in HeLa cells induces CAB formation23 and mutations 
in BUD16 gene, encoding Saccharomyces cerevisiae Pyridoxal kinase, result in gross chromosome rearrange-
ments24. More interestingly CAB frequency in Drosophila and human PLP-depleted cells was strongly enhanced 
by glucose treatment. In addition, PLP deficiency increases glucose content in dPdxk1 mutant hemolymph 
and causes AGE accumulation in neuroblasts. Treatment of dPdxk1 mutant cells with α-lipoic acid (ALA), a 
well-known AGE inhibitor, lowers both AGE formation and CAB frequency, suggesting a possible AGE-CAB 
cause-effect relationship. These findings indicate that a high intracellular glucose level has a dramatic clastogenic 
effect if combined with PLP deficiency and have prompted us to investigate if in diabetes low PLP levels can 
impair DNA integrity. Epidemiological studies clearly indicate that diabetes increases the risk of many types of 
cancer with mechanisms not yet fully understood. Possible links between these two diseases are hyperinsuline-
mia, hyperglycemia and fat-induced chronic inflammation. Several lines of evidence indicate that hyperglycemia 
may lead to cancer through DNA damage (reviewed in25). It is well known that high glucose causes DNA dam-
age by increasing the oxygen reactive species production via several mechanisms (namely the polyol pathway, 
hexosamine pathway, AGE pathway, and protein kinase C)26,27. Interestingly, oxidative damage and DNA strand 
breaks have been found in both type 1 and type 2 diabetic patients28–30.
To investigate if in diabetic cells PLP deficiency can impair genome integrity we used Drosophila as a model 
system. For the past decade Drosophila turned out to be a promising organism to model diabetes as flies and 
humans largely share mechanisms underlying the maintenance of balance between stored and circulating glucose 
(reviewed in31). Insulin pathway signaling, a biochemical pathway well conserved in flies (reviewed in32), plays a 
crucial role in glucose homeostasis maintenance as it triggers the uptake of glucose into liver, adipose tissue and 
muscle and promotes the storage of these nutrients in the form of glycogen. In humans and mice insulin pathway 
impairment, due to mutations, cause severe insulin resistance syndromes and type 2 diabetes (reviewed in33). Also 
in Drosophila malfunctioning of insulin signaling, induced either by mutations or by feeding flies with a sugar 
rich diet, produce diabetic hallmarks that mimic type 2 diabetes (reviewed in34).
In this work, we generated two different diabetic fly models, the first by depleting three well conserved pro-
teins involved in insulin pathway as InR, Chico (IRS) and Akt1 and the second by rearing flies in sugar rich diet35. 
We showed that PLP deficiency in both models of diabetes caused severe chromosome and DNA damage, proba-
bly through AGE accumulation in turn caused by high glucose levels.
These results allowed to generalize the concept that PLP deficiency combined with high glucose strongly 
impairs genome integrity, suggesting that in diabetic patients low PLP levels may represent a cancer risk factor.
Results
Generation of diabetic fly models. We previously demonstrated that low PLP levels, due to mutations in 
the encoding Pyridoxal kinase gene (dPdxk), cause CABs and increase glucose content in larval hemolymph23. We 
provided evidence that these phenotypes are linked because high glucose causes AGE accumulation which in turn 
is responsible for CAB phenotype23. Starting from these results, we asked whether low vitamin B6 levels could be 
genotoxic in diabetes. To answer to this question, we generated two fly models of type 2 diabetes (reviewed in31,34) 
using two strategies. In the first we silenced three evolutionarily conserved genes encoding proteins working in 
the insulin signaling pathway: Insulin receptor (InR), Insulin receptor substrate (Chico/IRS) and Akt1 (reviewed 
by32). In the second we reared wild type larvae on a high sugar diet (HSD) according to Musselman et al.35. To 
deplete InR and Chico we performed in vivo RNA interference (RNAi) in fat body (using the ppl-Gal4 driver), 
an organ analogue to vertebrate adipose tissue and liver, crucial for nutrient storage and energy metabolism. 
Targeted gene knockdown was detected by reverse transcriptase-PCR (see Supplementary Fig. S1). The effects of 
Akt1 depletion were evaluated using the hypomorphic late lethal allele Akt104226 and all experiments reported in 
this paper were conducted on hemizygous individuals (Akt104226/Df) to detect stronger phenotypes. Although in 
flies the most abundant circulating sugar is trehalose (a disaccharide formed by two glucose units) we focused on 
glucose as trehalose is a stable molecule and a non-reducing sugar36. In addition, evidence showed that glucose 
but not trehalose levels are regulated by mechanisms similar to those of higher organisms37. Glucose content in 
hemolymph from InRRNAi, chicoRNAi Akt104226/Df and HSD fed larvae was increased with respect to wild type and 
comparable to that exhibited by dPdxk1 positive control23 (Fig. 1A). In addition, InR and Chico RNAi-induced 
depletion, as well as HSD feeding, resulted in small size adults, a fly hallmark of insulin signaling impairment38–40 
(Fig. 1B–D; Supplementary Fig. S2). It was not possible to analyze body size in Akt104226/Df individuals as they 
die as third instar larvae.
Glucose treatment induces CABs in diabetic cells. Evidence shows that glucose induces chromosome 
damage41,42. Thus, we first asked whether the high glucose content present in InR, Chico and Akt depleted indi-
viduals and also in HSD fed larvae affected DNA integrity. DNA damage was evaluated in two different ways. In 
the first we examined chromosomes from Akt104226/Df, chicoRNAi and HSD fed third instar larvae in colchicine 
treated brain preparations (Fig. 2A), in the second, because of the low mitotic index induced by InR silencing, 
we examined γ-H2Av foci in InRRNAi brains fixed and immunostained with the pS137 anti-phospho-histone anti-
body that specifically recognizes γ-H2Av43 (Fig. 2C). γ-H2AV is the homolog of the mammalian γ-H2AX and 
represents a suitable marker to study DNA damage since it marks the DSBs44, which are known to be at the basis 
of CABs45.
Neuroblasts from chicoRNAi and HSD fed larvae exhibited frequencies of cells with broken chromosomes com-
parable to that of controls (0.5% and 0.3% respectively vs 0.44%) (Fig. 2B). Akt104226/Df cells displayed a small but 
significant CAB frequency (1.86%) (Fig. 2B). In this case CABs are not due to the high endogenous glucose con-
tent since Akt104226/Df mutants displayed hemolymph glucose levels comparable to those exhibited by chicoRNAi  
and HSD fed larvae (Fig. 1A).
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Since we previously showed that sugars such as glucose, fructose and sucrose strongly increased CAB fre-
quency in dPdxk1 neuroblasts23, we incubated brains from Akt104226/Df, chicoRNAi and HSD fed larvae in 1% glu-
cose and we tested them for CABs. In all examined cases (Fig. 2A,B) we found CABs ranging from 4.6% to 6.6%; 
in contrast glucose did not affect chromosome integrity in wild type neuroblasts, indicating that only diabetic 
cells are sensitive to extra sugar. Glucose treatment generated complex rearrangements; besides chromatid and 
isochromatid deletions (Fig. 2A2–A4), we observed dicentric chromosomes accompanied by acentric fragments 
(formed when two broken non homologous chromosomes join together end to end) and also cells containing 
more than one rearrangement (Fig. 2A5–A8). Glucose induced DNA damage also in InR depleted cells. While 
InRRNAi untreated larvae showed a percentage of γ-H2Av positive nuclei (4.5%) comparable to controls (4%), glu-
cose treatment significantly increased this frequency (11.7% vs 4.3% in controls) (Fig. 2C,D).
Together these data indicate that the addition of extra glucose to brains from chicoRNAi Akt104226/Df, InRRNAi 
and HSD fed larvae causes chromosome damage differently than wild type, suggesting that diabetic cells are sen-
sitive to glucose for CAB formation.
PLP deficiency induces high levels of DNA damage in diabetic cells. Our primary aim was to 
verify whether it is possible to generalize the assumption that a simultaneous occurrence of high glucose and 
low PLP affects genome integrity. Thus, we examined chromosome and DNA damage in our diabetic models 
deprived of PLP. To deplete PLP we employed two strategies: in the first we fed Akt104226/Df, InRRNAi, chicoRNAi 
and HSD reared larvae with a strong PLP antagonist, the 4-Deoxypyridoxine (4-DP), and in the second we gen-
erated Akt104226dPdxk1 double mutant individuals performing genetic crosses. 4-DP caused a substantial increase 
in chromosome breakage in chicoRNAi (~83-fold) Akt104226/Df (~55-fold) and HSD larvae (~64-fold) (Fig. 3A,B) 
clearly indicating that PLP deficiency strongly impacted on chromosome integrity in both diabetes models. A sig-
nificant, although lower, CAB increase (~24-fold) were also found in wild type 4-DP treated cells in agree with the 
PLP role in genome integrity maintenance, already demonstrated by our and other studies23,24. 4-DP enhanced 
CAB complexity more than glucose and produced cells with extensive chromosome fragmentation (Fig. 3A). 
As exactly quantifying the number of CABs in these cells was difficult, we decided to arbitrarily assign only five 
Figure 1. Diabetic hallmarks caused by insulin signaling impairment and high sugar diet (HSD) feeding. 
(A) Glucose content in hemolymph from wild type (wt), RNAi/mutant and HSD fed larvae. dPdxk1 was used 
as positive control. Columns are the means of 5 independent sample (20 larvae each) measurements ± SEM. 
***Significantly different in the Student’s t test with p < 0.001. (B) Examples of body size reduction observed in 
InRRNAi, chicoRNAi and HSD fed flies compared to wt control. (C) Examples of wing size reduction observed in 
InRRNAi, chicoRNAi and HSD fed flies compared to wt control. (D) Quantification of wing area reduction. Columns 
represent mean values of wing area reduction in InRRNAi, chicoRNAi and HSD fed flies compared to wt control. At 
least 30 wings per genotype were examined ***significantly different in the Student’s t test with p < 0.001.
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CABs to each cell with multifragmented chromosomes. As a consequence, CAB percentage reported in Fig. 3B 
may represent an underestimation. 4-DP also enhanced the frequency of γ-H2Av positive cells in InRRNAi larvae 
(24 vs 9.8% in control) (Fig. 3C,D). Interestingly most of 4-DP treated nuclei presented a foci pattern very similar 
to X rays-treated cells46 with a mean of about 40 foci per cell that is consistent with the complexity of chromosome 
rearrangements observed in 4-DP treated brains from chicoRNAi, Akt104226/Df and HSD fed individuals.
The examination of Akt104226dPdxk1 brain cells revealed a CAB frequency (23%) higher than the sum of the 
frequencies displayed by each single mutant (Akt104226 1.1%; dPdxk1 5%) (Fig. 3E). These data suggest a strong 
synergistic interaction between dPdxk1 and Akt104226 mutations confirming the hypothesis that CABs originate by 
a combination of high glucose and low vitamin B6 levels accordingly with results obtained with 4-DP.
Based on the consideration that dPdxk1 mutants contain more glucose than wild type strain we asked if PLP 
depletion could further increase glucose level in larval hemolymph from Akt104226/Df, InRRNAi, chicoRNAi and HSD 
fed individuals. As showed in Fig. 3F, 4-DP fed larvae exhibited a small but significant glucose content increase, 
with respect to untreated individuals.
Taken together these results indicate that in diabetic cells PLP deficiency strongly impairs DNA integrity.
AGEs contribute to DNA damage occurring in diabetic cells deprived of PLP. It is well known that 
PLP counteracts the accumulation of AGEs, genotoxic compounds abundant in most cells and fluid of diabetic 
patients14,15,47. AGEs originate from non-enzymatic amino group glycations of proteins, lipids and nucleic acids48,49, 
that accumulate during senescence and in high glucose conditions and their formation have been associated to reac-
tive oxygen species production26. To investigate the mechanism through which PLP protects from damage in high 
glucose conditions we immunostained untreated, 1% glucose and 4-DP treated brains from InRRNAi, ChicoRNAi and 
Akt104226/Df larvae using a human antibody against AGEs. We did not test HSD larvae for AGEs since we expected 
that there is the same mechanism at the basis of CAB formation in both models of diabetes. InR, Chico or Akt1 
Figure 2. Glucose supplement induces DNA damage in brains from chicoRNAi, Akt104226/Df, InRRNAi, and 
HSD fed larvae. (A) Examples of CABs observed in 1% glucose (G) treated brains from chicoRNAi, Akt104226/
Df and HSD fed larvae. Df is Df(3)Exel7328 that uncovers Akt1. (A1) wild type male metaphase; (A2) 
chromatid deletion of a major autosome, arrow; (A3) isochromatid deletion of a major autosome, arrow; (A4) 
isochromatid deletion of a major autosome, arrows; (A5) autosome-X chromosome dicentric chromosome 
(arrowhead) with acentric fragments, arrow; (A6) metaphase with extensive chromosome fragmentation; (A7) 
autosome-autosome dicentric (arrowhead) chromosome with acentric fragments (arrow) and isochromatid 
deletion of the X chromosome (arrow); (A8) metaphase with extensive chromosome fragmentation. Scale bar 
5 μm. (B) CAB frequencies. Un = untreated. G = 1% glucose. Each bar of the graph is the mean frequency of 
CABs ± SEM obtained examining at least 800 metaphases in at least 8 brains. * and *** significantly different 
in the Student’s t test with p < 0.05 and p < 0.001 respectively. (C) Examples and (D) frequencies of γ-H2Av 
foci observed in wild-type (wt) and InRRNAi brain nuclei untreated (un) and 1% glucose (G) treated. Bars show 
the mean values of three independent experiments ± SEM obtained by examining at least 500 cells/brain in 4 
brains. **Significantly different in the Student’s t test with p < 0.01.
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depleted neuroblasts showed AGE accumulation (Fig. 4A,B) more pronounced after glucose treatment. 4-DP feed-
ing further increased the frequency of cells positive to the anti-AGE staining in all examined cases (Fig. 4A,C). We 
next incubated Akt104226/Df, InRRNAi and chicoRNAi brains in 10 mM α-lipoic acid (ALA), an antioxidant compound 
that counteracts AGE formation and cooperates with PLP in ameliorating insulin resistance in prediabetic rats50,51. 
In all cases ALA treatment decreased AGE accumulation in both glucose and 4-DP treated cells (Fig. 4B,C). More 
Figure 3. Effect of PLP deficiency on chromosome and DNA integrity in diabetic larvae. (A) Examples of 
complex rearrangements and metaphases with multifragmented chromosomes observed in chicoRNAi and 
Akt104226 /Df neuroblasts from larvae fed with 4-DP 2 mM and from Akt104226 dPdxk1 double mutant larvae 
(Scale bar 5 μm). (B) CAB frequencies. †Significantly different in the Student’s t test with p < 0.001 compared to 
untreated counterparts. (C) Examples and (D) frequencies of γ-H2Av positive cells from wild type (wt) 
and InRRNAi untreated (un) and 4-DP 2 mM fed larvae. Bars show the mean values of three independent 
experiments ± SEM obtained by examining at least 500 cells/brain in 4 brains. ***Significantly different in the 
Student’s t test with p < 0.001. (E) CAB frequencies in Akt104226 dPdxk1 double mutant brains. Each column is the 
mean frequency of CABs ± SEM obtained examining at least 600 metaphases in at least 6 brains. Akt104226 dPdxk1 
CAB frequency was significantly higher than the sum of single mutant CAB frequency in Chi square test with 
p < 0.01. (F) Glucose content in hemolymph from 4-DP treated InRRNAi, chicoRNAi, Akt104226/Df and HSD feed 
larvae. *,** and *** significantly different in the Student’s t test with p < 0.05, p < 0.01 and p < 0.001 respectively.
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interestingly ALA also decreased DNA damage. As showed in Fig. 5A, in Akt104226/Df, and chicoRNAicells ALA treat-
ment reduced CAB frequency to control values in both glucose treated and 4-DP fed larvae. Similarly, ALA also 
lowered the percentage of InRRNAi γ-H2Av positive cells in neuroblasts from glucose treated and 4-DP fed larvae 
(Fig. 5B). These results suggested a cause effect relationship between AGEs and CABs and indicated that AGEs are 
largely responsible for chromosome and DNA damage occurring in diabetic PLP depleted cells.
PLP rescues glucose-induced DNA damage in diabetic cells. We previously demonstrated that PLP 
supplementation in both untreated and glucose treated dPdxk1 mutants rescued AGE accumulation confirming 
the role of vitamin B6 in counteracting these compounds also in Drosophila23. Based on these findings, we asked if 
PLP supplementation could reduce chromosome and DNA damage in Akt104226/Df, chicoRNAi and InRRNAi glucose 
treated brains. Thus, we reared mutant/RNAi larvae in food supplemented with 10−2 M PLP and examined them 
for CABs or γ-H2Av foci. To ascertain the PLP specificity we also tested brains from PLP fed individuals bearing 
twins (tws) mutation that causes a high frequency of CABs (about 40%) impairing a pathway uncorrelated with 
glucose metabolism46. PLP rescued glucose induced chromosome breakage in Akt104226/Df and chicoRNAi cells 
(Fig. 6A) but it did not influence CAB frequency in tws430 mutant brains (Fig. 6B) confirming its specificity. PLP 
also rescued the percentage of InRRNAi glucose treated γ-H2Av positive cells (Fig. 6C).
Taken together these data indicate that vitamin B6 improves glucose-induced DNA damage and strongly 
support the hypothesis that PLP is involved in chromosome integrity maintenance in high glucose conditions.
Remarkably PLP also rescued glucose content and body size in InRRNAi and ChicoRNAi individuals suggesting 
that vitamin B6 plays a role in ameliorating the tissue sensitivity to insulin (Fig. 7A,B). These findings are consist-
ent with our previous data23 indicating that Pdxk1 mutations cause a mild insulin resistance. Mechanisms linking 
PLP to insulin resistance will be the subject of future studies.
Discussion
For the past decade, Drosophila has been fast gaining popularity as a useful model system to study diabetes as it 
shares with humans mechanisms and molecules involved in hemolymph/blood glucose regulation. In Drosophila 
stable levels of circulating sugars are maintained by eight insulin-like proteins (Ilps) that are released in response 
to high glucose levels and by the adipokinetic hormone (AKH) that it is similar to glucagon and is released in 
Figure 4. InRRNAi, chicoRNAi and Akt104226/Df larvae accumulate AGEs that are increased by glucose and 4-DP 
treatment. (A) Examples of cells stained with an anti-human AGE antibody from untreated (un), 1% glucose 
(G) treated and 4-DP fed larvae. Scale bar, 5 μm. (B) Frequencies of AGE-positive cells in wild type (wt), 
InRRNAi, chicoRNAi and Akt104226/Df mutant brains untreated and exposed to 1% glucose (G) with or without 
α-lipoid acid (ALA). ALA treatment reduces drastically AGEs. (C) Frequencies of AGE-positive cells in wild 
type (wt), InRRNAi, chicoRNAi and Akt104226/Df mutant brains from 4-DP fed larvae untreated (un) and treated 
with ALA. Bars in B and C graphs represent the mean frequencies of AGE-positive cells (±SEM) obtained by 
examining at least 300 cells/brain in 4 brains. *,** and *** significantly different in the Student’s t test with 
p < 0.05, p < 0.01, p < 0.001 respectively.
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response to low levels of circulating sugar52–55. Type 1 and 2 diabetes have been modeled in Drosophila reproduc-
ing hallmarks of both diseases35,56–58 giving the chance to isolate new genes and identify functional interactions 
that can be exploited for therapeutic interventions on human patients.
We demonstrated that PLP deficiency due to mutations in dPdxk Drosophila gene causes DNA damage and 
increases glucose content in larval hemolymph. We showed that these phenotypes are correlated and that high 
glucose is largely responsible for DNA damage. In addition we showed that also in human HeLa cells the rela-
tionship between PDXK, DNA integrity and glucose content has been maintained in the course of evolution23.
In the present work we have provided evidences that PLP deficiency in fly diabetic cells strongly impair DNA 
integrity. We demonstrated the combined genotoxic effect of low PLP and high glucose levels using two different 
diabetes models, the first obtained by downregulating the expression of three well conserved insulin pathway 
genes: InR, chico and Akt1, and the second obtained by feeding flies with a high glucose diet (HSD). Both insu-
lin signal impairment and HSD feeding are considered promising strategies to model type 2 diabetes in flies34. 
Glucose levels obtained by depleting InR, Chico or Akt1 were similar to those obtained by Ugrankar et al.37, 
although we used a different fat body driver to silence InR and chico and also a different Akt1 allele.
We showed that high level of endogenous glucose caused by either insulin signaling impairment or HSD 
feeding is not sufficient to compromise DNA integrity. A possible explanation of this can be that fly metabolism 
relies mainly on treahalose that represents the more abundant circulating not-reducing sugar with ratio 100:1 
with respect to glucose. Thus, to observe glycation effects the system need to be forced by adding more glucose. 
We showed in fact that glucose treatment in Inr, Chico or Akt1 depleted brains as well as in neuroblast from HSD 
fed larvae caused CABs or γ-H2Av foci. In contrast glucose did not influence chromosome integrity in wild type 
cells suggesting that diabetic cells are more sensitive to glucose respect to wild type cells. We found that Akt104226/
Df mutants displayed a low frequency of CABs also in untreated cells. However, based on evidence indicating that 
the human AKT counterpart is involved in DNA integrity maintenance59 we think that CABs in these cells are not 
related to glucose metabolism, but are due to an improper DNA repair.
More importantly, we demonstrated that in both our hyperglycemic models, DNA damage was exacerbated 
when PLP levels were decreased by 4-DP, a strong PLP antagonist. 4-DP caused a dramatic CAB increase in chicoRNAi 
(83.6%), Akt104226/Df (57.4%) and HSD larval brains (64%) and also enhanced about 5 times the percentage of 
γ-H2AV positive cells in InRRNAi individuals with respect to untreated counterparts. 4-DP further increased glu-
cose content that, combined with an impaired antioxidant defense system, caused by PLP deficiency, may contrib-
ute to amplify chromosome and DNA damage. In addition we provided genetic evidence of a strong synergistic 
interaction between Akt1 and dPdxk1 mutations in CAB formation in double mutant individuals, accordingly 
with results obtained using 4-DP.
These results demonstrate that it is possible to extend the concept that low PLP levels cause DNA damage in 
high glucose conditions also to other diabetic contexts different from those caused by Pdxk1 mutation23.
Regarding the mechanism leading to CABs in diabetic PLP deprived cells we identified the pathway that leads to 
AGE formation as the best candidate that allow to correlate PLP, glucose and DNA damage. We showed that InRRNAi, 
chicoRNAi or Akt104226/Df diabetic cells accumulate AGEs which in turn are reduced by α-lipoic acid (ALA). More 
interestingly ALA also rescued both CABs and γ-H2Av foci suggesting a cause effect relationship between AGEs and 
CABs. As AGEs are known to be genotoxic through oxygen reactive species formation, these findings indicate that 
in diabetic cells PLP may safeguard genome integrity preventing AGEs from attack DNA. Our hypothesis is based 
on in vitro15 and in vivo studies showing that PLP is able to counteract AGE formation. It has been reported that PLP 
inhibits AGE accumulation in streptozotocin-induced diabetic rats, preventing the progression of nephropathy60. In 
addition, in glomerular cell nuclei of these rats PLP reduced the levels of carboxyethyl-2′deoxyguanosine (CEdG), a 
Figure 5.  α-lipoid acid (ALA) reduces DNA damage in InRRNAi, chicoRNAi and Akt104226/Df neuroblasts. (A) 
Effect of ALA on CAB frequencies in wild type (wt) chicoRNAi and Akt104226/Df neuroblasts 1% glucose (G) 
and 4-DP treated. Columns represent the mean frequency of CABs (±SEM) obtained by examining at least 
600 metaphases from at least 6 brains. * and *** significantly different in the Student’s t test with p < 0.05 and 
p < 0.001. (B) Effect of ALA treatment on γ-H2Av foci in wt and InRRNAi neuroblasts 1% glucose (G) and 4-DP 
treated. Bars show the mean values of three independent experiments ± SEM. ** and *** significantly different 
in the Student’s t test with p < 0.01 and p < 0.001.
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DNA glycation product that can cause strand breaks61. The exact mechanism through which PLP counteracts AGEs 
is not to date fully elucidated. A hypothesis is that PLP may block AGE formation by trapping the 3 deoxyglucosone 
(3-DG), an intermediate product of AGE metabolism. It has been in fact indicated, by in vitro experiments, that PLP 
is able to sequestrate 3-DG in a dose dependent manner62. However also other mechanisms are possible. PLP also 
works as a cofactor of enzymes that convert dUMP in dTMP. dPdxk1 mutants have an unbalanced amount of dUMP 
respect to dTMP23 but as are not sensitive to replication block induced by HU, this excess of dUMP does not seem 
to be the principal mechanism that leads to CABs. Anyway, we cannot exclude that nucleotide unbalance caused by 
PLP depletion can slightly affect chromosome stability in our diabetes models by influencing the rate of DNA repair. 
Furthermore, to the hypersensitivity of diabetic cells to 4-DP toxicity can contribute an impairment of DNA repair 
associated to diabetes. It has been demonstrated that diabetic patients showed, besides high levels of basal endoge-
nous and oxidative damage, an increased sensitivity to DNA damaging agents combined to a decreased capability to 
repair damage induced by these drugs63.
Altogether our data, extrapolated to human, strongly support the hypothesis that DNA damage represents one 
of the causative factors linking diabetes to cancer. In addition, they highlight the crucial role of PLP in chromosome 
stability maintenance in diabetic cells suggesting that low PLP levels can represent a critical cancer risk factor for 
diabetic patients. Low PLP levels in normal physiology represent a rare condition due to excessive consumption of 
alcohol, drugs commonly used to treat pathologies as tuberculosis or arthritis (e.i. isonyazide, cycloserine, penicil-
lamine) or celiac disease and renal dialysis64. However, interestingly, low PLP levels have been associated to diabetes 
in murine models and epidemiological studies65–67. In particular, a recent study68 based on the examination of three 
groups of individuals, diabetic, diabetic with nephropathy and healthy subjects, showed that respectively 63% and 
58% of diabetic patients with and without nephropathy presented low PLP plasma levels (<30 nM/L). Moreover, 
altered levels of PLP precursors pyridoxine and pyridoxamine have been found in diabetic patients suggesting an 
impaired PLP metabolism associated to diabetes. At the light of these considerations our findings suggest that in 
diabetic individuals PLP levels should be kept under control in order to limit the risk of DNA damage.
Methods
Drosophila strains and crosses. InRv992 and chicov7776 lines were obtained from the Vienna Drosophila Resource 
Center (VDRC) stock center. dPdxk1 mutation has been described previously23. ppl-Gal-4 driver52, Akt104226 and Df Exel 
7328 (89A12-89B6) lines were obtained from the Bloominghton Stock Center. InRRNAi and chicoRNAi flies were generated 
by crossing females bearing the RNAi construct to males carrying the fat body specific ppl-Gal4 driver. Mutations and 
deficiencies were kept in stock over the TM6C Sb, Tb balancer; homozygous and hemizygous mutant larvae were rec-
ognized for their non-Tubby phenotype. The Oregon-R strain was used as wild-type control.
Double mutants dPdxk1 Akt104226 were generated by recombination by crossing Akt104226/TM6C females to 
dPdxk1/TM6C males. Akt104226/dPdxk1 females resulting from this cross were mated to ApXa/TM6C males. Single 
males resulting from this cross were mated to ApXa/TM6C females. From these crosses were established about 
60 stocks crossing inter se males and females carrying recombinant chromosomes balanced over TM6 C. The 
presence of both mutations on the recombinant chromosomes was verified by complementation analysis. The 
balancers and the genetic markers used in these crosses are described in detail in FlyBase (http://flybase.bio.
indiana.edu/).
Fly food recipes. All flies, from embryo stage, were raised on a standard food. To induce insulin resist-
ance wild type larvae were reared on a sugar rich medium which is a standard food with an increased sucrose 
concentration. 100 ml food contains: agar (0.68 g), yeast (6.52 g), flour (3 g) propionic acid (600 µl) and sucrose 
(5.13 g = 0.15 M for standard food; 34.2 g = 1.0 M for high sugar diet, HSD).
Figure 6. PLP rescues CABs and γ-H2Av foci in chicoRNAi, Akt104226/Df and InRRNAi brains. (A) Effect of PLP 
on CAB frequencies in 1% glucose (G) treated wild type (wt), chicoRNAi and Akt104226/Df larval neuroblasts. 
Columns represent the mean frequency of CABs (±SEM) obtained by examining at least 600 metaphases from 
at least 6 brains. * and *** significantly different in the Student’s t test with p < 0.05 and p < 0.001 respectively. 
(B) Effect of PLP on tws430 CAB frequency. Columns represent the mean frequency of CABs (±SEM) obtained 
by examining at least 500 metaphases from at least 5 brains. (C) Effect of PLP on γ-H2Av foci in wt and InRRNAi 
1% glucose (G) treated neuroblasts. Bars show the mean values of three independent experiments ± SEM. *** 
significantly different in the Student’s t test with p < 0.001.
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Chromosome cytology. Colchicine-treated larval brain metaphases for CAB scoring were obtained as pre-
viously described69. For immunostaining, brains from third instar larvae were dissected and fixed as described 
in Bonaccorsi et al.70. Brain preparations were rinsed in PBS 0.1% Triton (PBST), incubated overnight at 4 °C 
with primary antibodies diluted in PBST, rinsed in PBST, and then incubated for 1 hr at room temperature 
with the secondary antibody. The primary antibodies used were: rabbit anti-Histone H2AvD pS137 (1:100 in 
PBST; Rockland code #600-401-914) and rabbit anti-human AGE antibody (1:200 in PBST; ab23722, Abcam, 
UK). Both antibodies were detected with Alexa-Fluor-555-conjugated anti-rabbit antibody (1:300 in PBST; 
Molecular Probes, Eugene, OR). All fixed preparations were mounted in Vectashield H-1200 with DAPI (Vector 
Laboratories, Burlingame, CA) to stain the DNA. Observations were carried out using a Zeiss Axioplan fluores-
cence microscope equipped with CCD camera (Photometrics CoolSnap HQ).
Drug treatments. To evaluate the effects of PLP inhibitor 4-deoxypyridoxine (4-DP) on CABs and γ-H2Av 
foci, flies were allowed laying eggs on a fly standard growth medium for 5 days. Then, adults were removed and 
4-DP 2 mM was added to medium (containing first and second instar larvae). 5 days later third instar larvae were 
dissected and brains fixed. For chromosome preparations brains were incubated 90 min in colchicine before fix-
ing. To detect γ-H2Av foci brains were treated according to immunostaining procedure.
To test the effects of glucose, PLP, and α-lipoic acid (ALA) on CABs and γ-H2Av foci, brains were dissected 
from third instar larvae and incubated in 2 ml of saline supplemented with 10% fetal bovine serum (FBS, Corning) 
for 4 hours with or without addition of 1% glucose, 1 mM PLP or 10 mM ALA. For chromosome preparations 1 h 
before fixation brains were treated with colchicine 10−2 M (final concentration). For γ-H2Av foci detection brains 
were treated according to immunostaining procedure.
Picture acquisition. Pictures of adult flies were taken using a Nikon D5200 digital camera mounted on a 
stereomicroscope (Nikon SMZ-1). Pictures were taken using a 1/6 second exposure, and 800 iso.
Glucose and wing measurement. Glucose concentration in Drosophila hemolymph was measured using 
the Infinity Glucose Hexokinase reagent (Thermo scientific). Hemolymph collection and glucose measurement 
were done as described in Marzio et al.23.
For wing analysis, flies were anesthetized with CO2. Dissected wings were placed in absolute ethanol, and 
mounted in a 6:5 mixture of lactic acid/ethanol71. Measurements were made directly on digitized images of 
mounted wings using ImageJ software.
Weight analysis. Body weight of individual male and female flies (n = 20) was measured with a precision 
weight scale (Gibertini E42; range 0.1 mg-120 g). Flies were reared under the same growth conditions and were 
age matched (2 days old) before weighing.
Nucleic acid extraction, PCR, and RT- PCR. Preparation of fly RNA, PCR, RT-PCR and agarose gel 
electrophoresis were performed with standard procedures. RNA extraction was performed with the RNeasy Mini 
Kit (Qiagen, Hilden, Germany). For RT-PCR we used 1 μg of RNA to synthesize complementary DNAs (cDNAs) 
using the Quantitect Reverse transcription kit (Quiagen cod # 205311) For cDNA amplification were used the 
following primers:
chico    F    CTGACATTCGTGTGCATTGGA
chico    R    ATGCTTGTTGGTTGAGTGCGG
Figure 7. PLP rescues glucose content and small body size in diabetic individuals. (A) Glucose content in 
InRRNAi and chicoRNAi larval hemolymph after PLP treatment. Columns are the means of 5 independent sample 
(20 larvae each) measurements ± SEM. *** significantly different in the Student’s t test with p < 0.001. (B) PLP 
treatment rescues body size in chicoRNAi and InRRNAi individuals. B1 Example of small body size in chicoRNAi (or 
InRRNAi); B2 rescued body size in chicoRNAi (or InRRNAi) flies treated with PLP.
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InR    F    GTGCTCCTCCGGTCTTATCGA
InR    R    GTGACGTTCAGCATAGCGGAG
rp49    F    TACAGGCCCAAGATCGTGAA
rp49    R    ACGTTGTGCACCAGGAACTT
Statistical analysis. Results are expressed as means ± SEM; probability values < 0.05 were considered statis-
tically significant. Statistical analysis of the data was done with the two-tailed Student’s t-test.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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